Today, AARP released the following statement from Executive Vice President and Chief Advocacy & Engagement Officer Nancy LeaMond. The statement is in response to seven drug company executives’ testimonies given at the Senate Finance Committee hearing, “Drug Pricing in America: A Prescription for Change, Part II.”
AARP Michigan posted several substantial victories on its legislative agenda during the recently concluded 2017-18 session of the Michigan Legislature.
AARP Michigan is part of the Michigan Dementia Coalition, which is developing a three-year plan for making the state more responsive to the needs of those with dementia. The coalition will publish its recommendations at the end of 2018 and share them with the new governor and lawmakers in early 2019.